1Staessen J A, Gasowski J, Wang J G, et al. Risks of untreated and treated systolic hypertension in the elderly: meta-analysis of outcome trials[J]. Lancet, 2001,355 : 865-872.
2The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcome in high-risk hypertension patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertension and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) [ J ]. JAMA,2002,288:2981-2997.
3Frohlich E D.Tteating hypertension-what are we to believe[J]? N Engl J Med,2003,348:639-641.
4Wing L M H, Reid C M, Ryan P, et al. A comparison of outcome with angiotensin-converting enzyme inhibitors and diuretic for hypertension in the dderly[J] .N Engl J Med,2003,348:583-592.
5Chalmers J.Chusid P.Cohan JN.et al.WHO-ISH Hypertension Guidelines Committee.1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension[J].J Hypertens,1999.17:151-183.
6Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diuretic North American setting:the Antihyperteasion and Lipid-lowering Treatment To Prevent Heart Attack Trial(ALLHAT) [J] .J Clin Hypertens,2003,4:393-405.
7Williams B. Drug treatment of hypertension-most patients will need a treatment cocktail including a thiazide diuretic[J]. BMJ,2003,326:61-62.
8Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report[J]. JAMA,2003,289: 2560-2572.
9Degli E E,Sturani A, Degli E L.et al. Pharmacoutilization of antihypertension drugs: a model analysis[J], Int J Clin Pharmacol The,2001,39: 251-258.
10August P. Initial treatment of hypertension[J] .N Engl J Med,2003,348:610-618.
